Skip to content
SEC filings edition: Friday, November 13, 2026 · 767 companies with filings Publisher's serviceBoardeon, your AI board · Hire your board →
Monday, November 16, 2026Every business day from SEC EDGAR
SEC EDGAR · Nov 13, 2026 1bankruptcies 11delisting notices 12late filings 43leadership changes 6IPO filings 199private raises 90earnings releases
Company page · CIK 1734005 · NIKI

Niki BioSolutions, Inc.

Filing with the SEC Foreign private issuer Princeton, NJ Nasdaq
An email when it files something new with the SEC. Your account

What this means

  • Several leadership changes3 reports of director or officer changes (Item 5.02) in the last 180 days.
  • Net loss in 2025Net loss of $1.4M for the year (2024: −$4.3M).

What to do next

Guides from the Companies Daily newsroom, picked for what the register shows.

Financials from XBRL

Calendar-year frame20252024
Net income (loss)−$1.4M−$4.3M
Total assets$18.7M$16.1M
Total liabilities$4.9M$4.4M
Stockholders’ equity$23.1M$21.1M
Cash and equivalents$3.5M$874K

From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.

Name as filed
Niki BioSolutions, Inc.
Formerly: Aptorum Group Ltd
CIK
0001734005
Tickers
NIKI
Kind of filer
Foreign private issuer
Non-accelerated filer; Smaller reporting company
Status
Filing with the SEC
State of incorporation
Cayman Islands
Business address
Princeton, New Jersey
Industry (SIC)
3829 · Measuring and controlling devices, n.e.c.
Industry: D · Manufacturing →
Fiscal year ends
December 31
Last annual report
20-F for the period ended Dec 31, 2025
Last quarterly report
—
Bankruptcy reported
Not in our data
Last edition event
Oct 13, 2026

Filing history

Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.

  • Director or officer change: CFO change
    Form 8-K · items 5.02, 9.01 · filed Oct 13, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 9.01 · filed Sep 4, 2026 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SCHEDULE 13D · filed Jul 24, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 2.01, 3.03, 5.02, 5.03, 8.01, 9.01 · filed Jul 20, 2026 · filing
  • Acquisition or disposal completed
    Form 8-K · items 2.01, 3.03, 5.02, 5.03, 8.01, 9.01 · filed Jul 20, 2026 · filing
  • Annual report (20-F): 20-F for the period ended Dec 31, 2025
    Form 20-F · filed Mar 27, 2026 · filing
  • IPO registration filed: Registration statement (F-1)
    Form F-1 · filed Nov 17, 2025 · filing
  • Annual report (20-F): 20-F for the period ended Dec 31, 2024
    Form 20-F · filed Apr 30, 2025 · filing
  • Annual report (20-F): 20-F for the period ended Dec 31, 2023
    Form 20-F · filed Apr 30, 2024 · filing
  • Annual report (20-F): 20-F for the period ended Dec 31, 2022
    Form 20-F · filed Apr 28, 2023 · filing